Terrie Curran - President and Chief Executive, Phathom Pharmaceuticals, Inc

As of May 20, 2022


What is Terrie Curran's Net Worth?

The current estimated net worth of Phathom Pharmaceuticals, Inc's President and Chief Executive, Terrie Curran, is estimated to be about $4.71M . Terrie Curran owns about 65,319 units of Phathom Pharmaceuticals, Inc common stock. In the last 2 years at Phathom Pharmaceuticals, Inc, Terrie Curran has sold an estimated value of $498.75K worth.

What is Terrie Curran's Past Insider Trading?

Terrie Curran's largest purchase order was 20,500 units , worth over $151.84K on May 16, 2022. Terrie Curran's largest sale order was 11,513 units , worth over $498.75K on March 23, 2021. In total, Terrie Curran has made about 6 transactions over 2 years of their time at Phathom Pharmaceuticals, Inc. Terrie Curran usually trades in May and January, with the busiest year in 2022.

Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What is Terrie Curran's' Mailing Address?

  • Mailing address is C/o Myovant Sciences Inc. 320 West 37th Street, 5th Floor New York NY 10018 NY

What are Phathom Pharmaceuticals, Inc's Past Insider Trades?

Phathom Pharmaceuticals, Inc's most recent insider trade came on May 16, 2022 by Azmi Nabulsi who bought 20,000 units worth $163.29K . In the last 3 years, insiders at Phathom Pharmaceuticals, Inc have sold an estimated value of $81.91M and bought an estimated value of $81.1M worth of shares. Insider trading is most common in May, with the busiest year in 2021. The most active traders at the company are Takeda Pharmaceutical Co Ltd,  David A Socks, Director,  and Azmi Nabulsi, Chief Operating Officer .

Phathom Pharmaceuticals, Inc. Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1